Detalles de la búsqueda
1.
Differential Effects of Genetic Polymorphism on Comorbid Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Clin Gastroenterol Hepatol
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38604296
2.
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications.
Clin Gastroenterol Hepatol
; 22(4): 789-797.e8, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048934
3.
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis.
Liver Int
; 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573034
4.
Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial.
Am J Gastroenterol
; 118(8): 1365-1372, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36656974
5.
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study.
Liver Int
; 43(10): 2210-2219, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470077
6.
Artificial intelligence/neural network system that accurately diagnoses hepatocellular carcinoma in nonalcoholic steatohepatitis.
Hepatol Res
; 53(12): 1213-1223, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37574654
7.
Impact of fibrosis on liver-related event incidence in nonalcoholic fatty liver disease: A multicenter observational study.
Hepatol Res
; 53(12): 1169-1184, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37534742
8.
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter study.
Hepatol Res
; 53(4): 312-321, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36524984
9.
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(6): 489-496, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807720
10.
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
Gut
; 71(5): 1006-1019, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34001645
11.
Serum levels of immunoglobulin M-free inhibitors of macrophage/CD5L as a predictive and early diagnostic marker for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Hepatol Res
; 52(12): 998-1008, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35939571
12.
Comparison of thrombocytopenia between patients with non-alcoholic fatty liver disease and those with hepatitis C virus-related chronic liver disease.
Hepatol Res
; 52(8): 677-686, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35543116
13.
Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
Hepatol Res
; 52(3): 235-246, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861090
14.
Misunderstanding of hepatitis C virus (HCV) infection status by non-specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy.
J Infect Chemother
; 28(9): 1231-1234, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35534339
15.
Novel artificial intelligent/neural network system for staging of nonalcoholic steatohepatitis.
Hepatol Res
; 51(10): 1044-1057, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34124830
16.
Artificial intelligence/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Hepatol Res
; 51(5): 554-569, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33594747
17.
A novel rapid immunoassay of serum type IV collagen 7S for the diagnosis of fibrosis stage of nonalcoholic fatty liver diseases.
Hepatol Res
; 51(3): 263-276, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33350036
18.
Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-ß1/SMAD Signaling and Autophagy in Hepatic Stellate Cells.
Int J Mol Sci
; 22(24)2021 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34948151
19.
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan.
J Gastroenterol Hepatol
; 35(8): 1420-1425, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31950525
20.
Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
J Gastroenterol Hepatol
; 35(5): 855-861, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31609495